Pacific Biosciences of California Inc. buy Cantor Fitzgerald
Start price
31.10.23
/
50%
€6.27
Target price
31.10.24
€10.36
Performance (%)
-73.70%
Price
10.05.24
€1.65
Summary
This prediction is currently active. Massive losses of -73.70% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 31.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | -2.808% | -2.808% |
| iShares Core DAX® | 4.094% | 3.543% |
| iShares Nasdaq 100 | 1.424% | 0.512% |
| iShares Nikkei 225® | -1.572% | -4.633% |
| iShares S&P 500 | 1.822% | 0.963% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat